Clinical Trials Logo

Filter by:
NCT ID: NCT04210531 Completed - Dietary Supplement Clinical Trials

Beetroot Juice Supplementation in Basketball Players

Start date: June 9, 2019
Phase: N/A
Study type: Interventional

Whereas beetroot juice (BJ) supplementation is shown to increase physical performance in endurance activities, its benefits in team sports has been barely studied. In this randomized placebo-controlled study, we investigated the effects of BJ acute supplementation in improving neuromuscular performance and physical match activity in basketball.

NCT ID: NCT04210518 Completed - Clinical trials for Proprioceptive Disorders

Balance Training With Stroboscopic Vision

Start date: May 2, 2019
Phase: N/A
Study type: Interventional

Balance training with stroboscopic vision in patients with chronic ankle instability.

NCT ID: NCT04210336 Completed - HPV Infection Clinical Trials

Clinical Trial to Evaluate Papilocare® Gel Efficacy Into Repairment of Cervical Lesions Caused by HPV

PAPILOCAN
Start date: August 7, 2018
Phase: N/A
Study type: Interventional

Clinical Trial phase III, randomized, double-blind, placebo-controlled and parallel-group clinical trial to evaluate the efficacy of Papilocare gel in the repair of cervical lesions caused by HPV. The study is divided into two parts. All patients included in the study will be randomized (1: 1) to one of the 2 study groups, Papilocare or placebo, using a randomization list and in double-blind conditions.

NCT ID: NCT04209114 Completed - Bladder Cancer Clinical Trials

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Start date: February 5, 2020
Phase: Phase 3
Study type: Interventional

The purpose of the study is to see if treatment with nivolumab plus bempegaldesleukin or nivolumab alone, before and after surgery to remove the bladder, is more effective than surgery alone in participants with high-risk urothelial cancer, including muscle-invasive bladder cancer who are not able to receive cisplatin chemotherapy.

NCT ID: NCT04207697 Completed - Clinical trials for Rhinoconjunctivitis With or Without Allergic Asthma

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander

Start date: December 1, 2019
Phase:
Study type: Observational

Non-interventional Study to Assess the Safety and Effectiveness Profile of a SCIT Therapy With Beltavac® Polymerized With Cat Dander in allergic patients

NCT ID: NCT04207684 Completed - Healthy Volunteers Clinical Trials

Generation of Biological Samples Positive to Testosterone for Anti-doping Control

TST
Start date: February 4, 2020
Phase: Phase 1
Study type: Interventional

Background: Testosterone is a steroid widely known to improve physical performance due to its protein-anabolic effect. Like other androgenic anabolic steroids (EAA), testosterone is included on the World Anti-Doping Agency (WADA) list of prohibited substances. EAA are the most detected banned substances in anti-doping controls. Therefore, different analytical strategies are required to improve its detection. Hypothesis: The intramuscular administration of 250 mg of testosterone (cypionate) in healthy subjects allows generating detectable concentrations of the drug in urine. Positive urine samples will enable to identify analytical strategies for doping control. Objectives: Primary objective: To measure the concentrations of testosterone in urine for anti-doping control samples. Secondary objective: To identify metabolites and precursors of testosterone in urine. To assess safety and tolerability of the drug used. Methods: Phase I, open, non-randomized clinical trial, with a treatment condition (testosterone) administered via intramuscular injection to 4 subjects.

NCT ID: NCT04206605 Completed - Angioedema Clinical Trials

A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)

Start date: May 4, 2020
Phase: Phase 3
Study type: Interventional

The main aim of this study is to check if repeated subcutaneous (SC) injections of lanadelumab can prevent angioedema attacks in teenagers and adults with non-histaminergic angioedema with normal C1-INH. Another aim is to check if they tolerate the repeated SC injections. Participants will receive a SC injection of lanadelumab every two weeks for 26 weeks. The first two doses of lanadelumab will be given at the study clinic. Once a participant (and/or parent/caregiver) has been appropriately trained, lanadelumab can be self-injected. Visits to the study clinic are planned for the first, third and fourth week and then every 4 weeks.

NCT ID: NCT04206592 Completed - Airway Management Clinical Trials

Comparison of the Ambu AuraGain and Intersurgical i-Gel Laryngeal Masks in Elective Laparoscopic Cholecystectomy

Start date: November 18, 2019
Phase: N/A
Study type: Interventional

Prospective, controlled, randomized study to compare Ambu AuraGain with Intersurgical i-Gel mask during mechanical ventilation in patients undergoing laparoscopic cholecystectomy. The investigators hypothesise that when comparing the Ambu® AuraGainTM with Intersurgical i-GelTM mask, the Ambu® AuraGainTM would exhibit a higher oropharyngeal leak pressure (OLP) during mechanical ventilation in patients undergoing laparoscopic cholecystectomy. The main goal is to compare the Ambu AuraGain with the i-Gel in terms of safety and efficacy during mechanical ventilation in critical phase of the pneumoperitoneum in lateral decubitus and reverse trendelemburg position. Secondary objectives are comparing insertion time, number of attempts, ventilatory airway peak pressure, time and success rates for gastric tube insertion and the incidence of side effects.

NCT ID: NCT04206449 Completed - Clinical trials for Obstructive Sleep Apnea (OSA)

Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA)

TERMOAPNEA
Start date: September 10, 2018
Phase: N/A
Study type: Interventional

To assess the diagnostic validity and cost-effectiveness of an infrared thermography system in adults with clinical suspicion of Obstructive Sleep Apnea (OSA).

NCT ID: NCT04205019 Completed - Clinical trials for Spinal Cord Injuries

Safety Stem Cells in Spinal Cord Injury

SSCiSCI
Start date: November 14, 2020
Phase: Phase 1
Study type: Interventional

Mono-center, open label study to investigate the safety of Neuro-Cells in 10 end stage (chronic) traumatic spinal cord injury (TSCI) patients, when administered once intrathecally. TSCI is a rare disease without cure perspectives and Neuro-Cells is an autologous fresh stem cells containing product (one batch / one patient).